NoNo - here is the PR
BioShield Cancels Existing Equity Lines of Credit; Old Equity Instruments No Longer Needed; Reduces Overhang in Market
ATLANTA, Oct. 5, 2001 -- BioShield Technologies, Inc. (OTC Bulletin Board: BSTI) announced today that all current equity lines of credit would be cancelled. Profits gained from the sale and licensing of its chemicals combined with a recently signed $1,000,000 line of conventional A/R financing should be adequate to fund operations, stated management.
This week BioShield reported its first profitable quarter ever along with the signing of a $35 million, 7-year contract for the licensing and distribution of its patented chemicals. Management has estimated margins on that contract and other contracts currently under negotiation will reach 80%.
About BioShield:
BioShield's Patented chemical is the world's first water-based residual antimicrobial liquid. When sprayed on a surface, it kills and prevents the re-growth of salmonella, e-coli and strep bacteria. It also destroys mold, mildew, viruses and fungi. It continues to disinfect for one month to three years, depending on the surface. Conventional antibacterials kill bacteria and disinfect the surface, but as soon as they dry, they no longer work. BioShield's active molecule binds itself to the surface. You could come back six months later and it would still kill all the viruses and germs. BioShield's antimicrobial doesn't leech off into the environment. You could put it on a surface and lick that surface and it would not come off. It will last the longest, maybe for years, on a fiber surface, like carpet or upholstery. On a hard surface, it may last one to three months because you never know what a consumer will do to that surface, such as using [an abrasive cleaner], which is just like sandpaper.
News 
Market Data 
Discover 
AI
